Unknown

Dataset Information

0

Prognostic value of intratumoral metabolic heterogeneity on F-18 fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced cervical cancer patients treated with concurrent chemoradiotherapy.


ABSTRACT: To evaluate the prognostic value for predicting tumor recurrence of intratumoral metabolic heterogeneity and traditional quantitative metabolic parameters on pre-treatment F-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy (CCRT).Ninety-three patients with biopsy-proven cervical cancer and treated with CCRT (FIGO stage IIB-IV) were enrolled in this study. The traditional metabolic parameters of the primary tumor, regional lymph node, and whole body (maximum standardized uptake value [SUVmax], metabolic tumor volume [MTV], and total lesion glycolysis), and intratumoral heterogeneity factor (HF) were measured on pre-treatment 18F-FDG PET/CT images. Univariate and multivariate analyses for disease-free survival (DFS) were performed using clinical and metabolic parameters. The additional HF prognostic value was evaluated by means of time-dependent receiver operating characteristic curve, integrated discrimination improvement, and net reclassification improvement.On multivariate analysis, nodal SUVmax (hazard ratio 3.60; 95% CI, 1.66-7.85; p = 0.0012) and whole body MTV (WBMTV; hazard ratio 3.15; 95% CI, 1.17-8.53; p = 0.0236) were significant prognostic factors for DFS. When HF was combined with nodal SUVmax and WBMTV, a significant improvement in discrimination for recurrence was observed compared with nodal SUVmax alone (area under curve 0.817 vs. 0.732; p = 0.0028).HF did not show superiority over traditional metabolic parameters. However, when HF was combined with nodal SUVmax and WBMTV, the predictive value for tumor recurrence improved. Therefore, HF may be a useful additional prognostic biomarker to improve the prognostic value of traditional metabolic parameters on 18F-FDG PET/CT.

SUBMITTER: Chong GO 

PROVIDER: S-EPMC5685760 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prognostic value of intratumoral metabolic heterogeneity on F-18 fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced cervical cancer patients treated with concurrent chemoradiotherapy.

Chong Gun Oh GO   Lee Won Kee WK   Jeong Shin Young SY   Park Shin-Hyung SH   Lee Yoon Hee YH   Lee Sang-Woo SW   Hong Dae Gy DG   Kim Jae-Chul JC   Lee Yoon Soon YS  

Oncotarget 20170628 52


<h4>Objective</h4>To evaluate the prognostic value for predicting tumor recurrence of intratumoral metabolic heterogeneity and traditional quantitative metabolic parameters on pre-treatment F-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy (CCRT).<h4>Materials and methods</h4>Ninety-three patients with biopsy-proven cervical cancer and treated with CCRT (FIGO stage  ...[more]

Similar Datasets

| S-EPMC4647251 | biostudies-literature
| S-EPMC10582033 | biostudies-literature
| S-EPMC7403810 | biostudies-literature
| S-EPMC8648629 | biostudies-literature
| S-EPMC5529320 | biostudies-other
| S-EPMC4839768 | biostudies-literature
| S-EPMC7181584 | biostudies-literature
| S-EPMC11309150 | biostudies-literature